Related Experiment Video
Updated: Dec 26, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs
Peng Kuang1, Peixin Chen2,3, Lei Wang2
1Department of Medical Oncology, The First Affiliated Hospital Of Nanchang University, Nanchang 330006, China.
Background:
The further progression of credible expression profiling analysis of genes continues to expand our understanding of the biological characteristics in lung cancer. In this study, RNA sequencing (RNA-Seq) was used to contrast the transcriptomics profiling of small cell lung cancer (SCLC) that acquired partial response (PR) and stable disease (SD)/progressive disease (PD) after first-line chemotherapy. We aimed to illuminate the underlying mechanisms of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) in the efficacy of SCLC first-line chemotherapy.
Methods:
Six male patients (mean age, 64.2 years) with SCLC were enrolled in this study. RNA-Seq was executed on the tumor tissues from 3 patients with PR outcome and 3 patients with SD or PD therapeutic effect after first-line chemotherapy.
Results:
RNA-Seq generated 26.67×106 (±8.7×106) reads in SCLC tissues [mean (±standard deviation)]. Analysis revealed that 64 lncRNAs had higher expression and 194 had lower expression in the PR group ≥2-fold (P<0.05). Three downregulated genes in the PR group [HOXA-AS3, cancer susceptibility 9 (CASC9), and KEGG] could have a role in the insensitivity of SCLC. A total of 1,303 differential miRNAs were defined between PR and the SD or PD SCLC group, while 520 miRNAs had higher expression, and 783 had lower expression in the PR group. Two lower expressed miRNAs in the PR group (miRNA 601 and miRNA 596) might be the key genes in SCLC chemotherapy insensitivity.
Conclusions:
The expression of 3 gene (HOXA-AS3, CASC9, and KEGG) and 2 miRNAs (miRNA 601 and miRNA 596) were markedly decreased in SCLC patients who achieved PR. They thus might be the promising candidate genes in SCLC chemotherapy insensitivity.
Insights
This study identified key genes and microRNAs (miRNAs) that are downregulated in small cell lung cancer (SCLC) patients responding to chemotherapy. These findings may help predict treatment response and develop new strategies for SCLC chemotherapy insensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Gene expression profiling enhances understanding of lung cancer biology.
- Small cell lung cancer (SCLC) treatment efficacy is a critical area of research.
- Identifying molecular mechanisms of chemotherapy response in SCLC is essential.
Purpose of the Study:
- To contrast transcriptomics profiling in SCLC patients with partial response (PR) versus stable/progressive disease (SD/PD) after first-line chemotherapy.
- To investigate the roles of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) in SCLC chemotherapy efficacy.
- To identify potential biomarkers for predicting SCLC treatment outcomes.
Main Methods:
- RNA sequencing (RNA-Seq) was performed on tumor tissues from six SCLC patients.
- Patients were categorized into PR and SD/PD groups based on their response to first-line chemotherapy.
- Differential expression analysis was conducted for lncRNAs and miRNAs.
Main Results:
- Significant differences in lncRNA and miRNA expression were observed between PR and SD/PD groups.
- Three downregulated genes (HOXA-AS3, CASC9, KEGG) and two miRNAs (miRNA 601, miRNA 596) were identified in the PR group.
- These identified genes and miRNAs may be associated with SCLC chemotherapy insensitivity.
Conclusions:
- Downregulation of HOXA-AS3, CASC9, KEGG, miRNA 601, and miRNA 596 was noted in SCLC patients achieving PR.
- These molecular markers show potential as predictive indicators for SCLC chemotherapy response.
- Further research into these candidates could lead to improved therapeutic strategies for SCLC.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs

